chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported Friday 08/11/2023 that after the vaccine, the vaccination site got red, feels hot and has a bump. She reported that day because the bump got bigger and Thursday she felt sick. Advised her to see a doctor if she feels she have to. I followed up the following Monday and she said the bump subsided and does not feel hot anymore but it's still red. She didn't go to the doctor.
Varicella - Information has been received from a school nurse concerning sight patients who were vaccinated with one dose of varicella virus vaccine live in the past (unknown site ) . subsequently the patients developed chicken pox.  An unspecified number of the patients sought unspecified medical attention.  Theere wer 105 cases of varicella in the school, but only eight of the patients were confirmed varicella virus vaccine live vaccine on a crude study by the school nurse.  follow up was received for one specified patient wases 01033292.  Additonal information has been requested.
PCR positive same day/exposed at dinner event; PCR positive same day/exposed at dinner event; Congestion; Dry cough; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 51 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 50 years as dose 3 (booster), single, administration date 15Mar2021 (Lot number: EL3247) as dose 2, single and administration date 22Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 20Feb2022, outcome "unknown" and all described as "PCR positive same day/exposed at dinner event"; NASAL CONGESTION (non-serious) with onset 20Feb2022, outcome "unknown", described as "Congestion"; COUGH (non-serious) with onset 20Feb2022, outcome "unknown", described as "Dry cough". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (21Feb2022) negative, notes: Other; (21Feb2022) positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of covid-19, nasal congestion, cough.  Clinical course: 17Feb2022 Exposed at dinner event and then SX started 20Feb2022 congestion and dry cough and HA then Ag neg 21Feb2022 but PCR positive same day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: A causal association between BNT162B2 with reported vaccination failure & covid-19 cannot be excluded based on provided information.
Pt first noticed a hard nodule at injection site. Area started to turn red, swollen and warm to the touch. Redness started spreading and pt noticed little shooting pains. Pt was given 80 mg DEPOMEDROL 2 days later. Sx are improving.
Symptoms : Itchy welts on chest, abdomen, back, face and both UL's. Tingling of the mouth and face.  Swollen lip, dizziness and shortness of breath. Treatment: onsite intravenous steroids and anti-histamines. prescription of Gosall 20mg daily x 7 days and Prednisone 40mg daily x 5 days.
Fever that started around 9:00 a.m. and continued through at least 11:00 p.m. Highest temperature of 100.9  Achiness in joints, especially tops of legs.
9/1/21: Patient arrived at the ER due to cough and congestion as well as shortness of breath. Patient is on room air with oxygen saturation of 98% awaiting bronchoscopy with ultrasound-guided FNA of the mediastinal mass.  Please note: Patient received first dose Pfizer vaccine on 3/30/2021 Lot # EP7533 and the second dose on 4/12/2021 Lot # EW0153
Discharge Provider: MD Primary Care Provider: DO Admission Date: 2/21/2023 Discharge Date: Feb 25, 2023 PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:   Patient is a 88 y.o. female with medical history significant for coronary artery disease, hypertension, dyslipidemia, CKD stage IIIA, prior stroke, dementia.  Presents ER for weakness over the past day.  History gathered from chart review, patient has dementia (A&Ox2-3 at baseline) .   Recent admission 1/4-1/6/2023 (notes reviewed) after presenting to ER for weakness and fatigue as well as cough, admitted for sepsis syndrome and lactic acidosis.  COVID-19, influenza, RSV negative.  Urinalysis showing significant pyuria and labs showing leukocytosis so patient started on IV Rocephin for possible urinary tract infection.  Also started on IV fluids.  Blood and urine cultures negative however patient's symptoms improved with fluids and antibiotics.  PT/OT evaluated patient who recommended discharge home with assistance.  Working with PT following discharge with improvement in strength, discharged from PT on 02/15 due to patient meeting goals and being independent with home exercise programs with daughter's supervision.   Back to ER evening of 2/21 reportedly due to increasing weakness over the previous 12 hours.  She had been ambulating independently with a walker, but this evening, was unable to even stand due to weakness.  Patient herself says she feels well, does report a cough for 2 weeks as well as weakness, otherwise denies concerns.  No headache, chest pain or pressure, shortness of breath, abdominal pain, vomiting, diarrhea or bowel changes.  Denies known sick contacts. Received last COVID-19 booster in 10/2021.   In ER, noted to be febrile with T-max 102.7° F, mildly tachycardic and tachypneic, vitals otherwise stable.  No hypoxia.  Labs unremarkable.  UA negative.  CXR.  Found to be COVID-19 positive.  Due to significant weakness and inability to safely return home, will place in observation for further management and safe dispo. Pt was observed for 24 hrs. Labs and VS wnl. PT/OT consulted for placement. Recs SAR.This was discussed with pts daughter. On day of discharge pt feels well. Denies any complaints. Stable for discharge.
My period started inexplicably early and was extremely heavy. On my heaviest day I went through a super tampon and super pad and had a major leak incident. After that first incident it happened two more times each 45 minutes apart.  After my second shot about a week and a half later I started to have a period again, which my other one had just ended a week prior.
pts mom states pt was up crying all noc p/vax; fever of 100.8;
High blood pressure; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and penicillin allergy. The patient received other medications(unspecified) within 2 weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 on 12:00, the patient experienced high blood pressure. The treatment received for the reported event was unknown. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event high blood pressure was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a 12 month old male who "last month", in October 2006, was vaccinated with a 0.5 mL dose of Proquad. Subsequently, 10 days after the patient was vaccinated he developed a fever of 103 degrees which subsided after 24 hours. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Received over 65 high dose flu shot. At around 7:00 PM the following started and continued until 10:00 A.M. 10/24/2014 A.M. Chills, horrible pain at kidney area, left leg pain, constant urinating every 45 min to an hour. Very hard time standing and walking with kidney and leg pains.
Fatigue, low grade fever, chills, nausea,  body aches, unusual sence of taste. Sx resolved on their own after 3 days.
Information has been received from a registered nurse concerning a 12 month old (currently 5 year old) female patient who on an unspecified date, was vaccinated with a dose of MMR II (Lot #, dose and route not reported). The registered nurse reported that on 03-OCT-2007, at twelve months of age, the patient had an anaphylactic reaction (trouble breathing and hives) to MMR II. The registered nurse reported that she was not sure, but she believed that on an unspecified date, the patient visited the emergency room and had office visit, but was unsure if the patient was hospitalized. The nurse stated that she had no information about the duration of the anaphylactic reaction. On an unspecified date, the patient was recovered from the event. On an unspecified date, the patient was tested for allergies to egg after the anaphylactic reaction to MMR II and was found to be allergic to eggs. The anaphylactic reaction (trouble breathing and hives) was considered to be immediately life threatening by the reporter. No further information is available.
On the evening of 4/20/21, I was sitting on a bench watching a track meet, when I began to experience dizziness, and disorientation.  I went to sleep that night hoping the symptoms would subside.  The next morning,  Iwent to work (as a plumber) but was not able to leave the work truck due to the dizziness.  That afternoon, I went to the ER where tests showed I had a left occipital infarct.   On 8/1/21,  approximately 6pm, I had total numbness on my left side.  I called 911 right away and was admitted to the hospital where they diagnosed an ischemic stroke in the right frontal lobe.    Prior to the vaccine, I have no history of strokes.
At the  3rd day from the vacine aplicacion was 2nd of nobember   headache.  All day. 3rd november  headache sore throat and fever. Went to the doctor for 1st time Doctor. Gave me some ibuprofen and paracetamol  to relieve the symptoms.  From 4th Nov to 7th Nov I stay in home with little symptoms of  fever an weakness   .8ht nov was felling good so I went to work at the afternoon start to felt fever again . Since that day still got  fever during night and day
diarrhea/malaise & subsequent swelling of inj arm several hr (<12) p/vax;
Information has been received from a physician via medical records concerning a 10 week old female, who on 05-AUG-1992 was vaccinated with a first dose of hepatitis B virus vaccine (unspecified) (manufacturer unknown). On 13-OCT-1992 she was vaccinated with a second dose of RECOMBIVAX HB (lot # 603895/0748V, also reported as 0748O) in her left leg. The patient was vaccinated with a third dose of ENGERIX-B (lot # ENG097A2) in her left leg (vaccination date reported as 24-FEB-1992). Concomitant therapy included doses of ACEL-IMUNE, poliovirus vaccine and HIBTITER. On 09-JUN-2010 the patient had a hepatitis B surface antibody test (<5 mIU/mL); It was reported that the patient did not develop immunity to hepatitis B virus after the initial hepatitis B vaccination series. On the same date the patient had a varicella zoster virus antibody IgM test (0.24 ISR) and a varicella zoster virus antibody IgG test (2.03). The patient also received the following vaccines: the first dose of MMR II (lot # 603966/0537W) in her left arm on 03-NOV-1993; the second dose of MMR II (lot # 638512/0165L, HSA) in her left arm on 13-AUG-2001; the first dose of ADACEL (lot # 01340AA) in her left arm; the first dose of influenza virus vaccine (unspecified) (manufacturer unknown) on 28-OCT-2005; second dose of influenza virus vaccine (unspecified) (manufacturer unknown) on 29-DEC-2006, third dose of influenza virus vaccine (unspecified) (manufacturer unknown) on 19-NOV-2007; first dose of MENACTRA (lot # 42619AA) in her left arm on 23-JUN-2008; fourth dose of influenza virus vaccine (unspecified) (manufacturer unknown) on 13-OCT-2008 and fifth dose of influenza virus vaccine (unspecified) (manufacturer unknown) on 01-SEP-2009. At the time of the report the patient's present status was unknown. This is one of several reports received from the same source. Additional information is not expected.
An immunocompromised patient only received a booster (50mcg) dose of the Moderna COVID-19 vaccine instead of full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (An immunocompromised patient only received a booster (50mcg) dose of the Moderna COVID-19 vaccine instead of full dose) in a 12-week-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, the patient experienced ACCIDENTAL UNDERDOSE (An immunocompromised patient only received a booster (50mcg) dose of the Moderna COVID-19 vaccine instead of full dose). On 22-Oct-2021, ACCIDENTAL UNDERDOSE (An immunocompromised patient only received a booster (50mcg) dose of the Moderna COVID-19 vaccine instead of full dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.
9x5.5cm oval warm red, firm area surrounding injection site of PENTACEL. Was improving in the 10hrs prior to OV. More central clearing at OV.
Sore arm; Dizziness; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder since 1975, Blood pressure high since 1975, Anxiety since 1975, Acid reflux (esophageal) and Penicillin allergy. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), PAROXETIN [PAROXETINE] for Anxiety, IRBESARTAN and EZETIMIBE for Blood pressure high, ATORVASTATIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue). On 13-Feb-2021, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Completed ADR Form included updated reporter details, patient demographic details, medical history, allergic information, concomitant medication, event outcome details.
Dose administered after more than 12 hours post punctured; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post punctured) in a 40-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 022J21A) for COVID-19 vaccination.     Concurrent medical conditions included Reflux gastritis since 04-Apr-2022. Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for an unknown indication.    On 04-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post punctured) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No treatment medication information provided. Hight: 6 feet 7 inch. Weight: 232 Ibs.
After shot #2, my period cramps caused me to vomit from the severity of the pain; After shot #2, my period cramps caused me to vomit from the severity of the pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jul2021 as dose 2, single (Lot number: EW0198) at the age of 29 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: gluten" (unspecified if ongoing); "known allergies: sulfa-based antibiotics" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Ibuprofen, reaction(s): "known allergies:ibuprofen". Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0196, Location of injection: Arm Right, ), administration date: 24Jun2021, when the patient was 29-year-old, for COVID-19 immunization, reaction(s): "Loss of consciousness", "Dysmenorrhoea", "COVID-19". The following information was reported: VOMITING (non-serious), DYSMENORRHOEA (non-serious) all with onset 2021, outcome "unknown" and all described as "After shot #2, my period cramps caused me to vomit from the severity of the pain". Relevant laboratory tests and procedures are available in the appropriate section.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200931829 same patient, same drug, different dose/event;
This is a spontaneous report that has been received from the patient's mother concerning a 7 year old male patient. On 21-APR-2014 the patient was vaccinated with PNEUMOVAX 23, 0.5 ml, once shot, unspecified route of administration, for born with no spleen. Penicillin was reported as a concomitant medication. There were not medical history and drug allergies. The patient's mother reported that on 21-APR-2014 (also reported as a half an hour after receiving PNUEMOVAX 23) the patient started to become red, swollen and was in pain. It became progressively worse over time went by. BENADRYL and TYLENOL were given as treatment for the patient started to become red, swollen and was in pain. Laboratory diagnostics studies were performed. The patient sought medical attention. The outcome of the patient started to become, swollen and was in pain, was reported as recovering/resolving (also reported as only now the patient seems like he is recovering from the adverse events). Additional information has been requested.
Information has been received from a physician concerning an 80 year old female consumer who on an unspecified date was vaccinated with zoster vaccine live (Oka/Merck). Subsequently, the patient developed a zoster rash over her entire body 2 weeks after vaccination. Medical attention was sought in the office with a specialist. It was unspecified if lab studies were performed. The specialist diagnosed the rash as zoster. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Severe muscular pain in both lower extremites extending up to hip area starting 3 days after the shot and continueing for11 days, getting less intense towards the end of the  11 days; This is a spontaneous report from a contactable nurse, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN5318) via an unspecified route of administration on 17Feb2021 at 09:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, hypertension (HTN), low thyroid, deep vein thrombosis (DVT) and allergic to non steroidal anti inflammatory drugs (NSAIDS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), amlodipine besilate (NORVASC), vitamin d nos (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), citalopram hydrobromide (CELEXA) and acetyl salicylic acid (ASA); all for unknown indications from an unknown date and unknown if ongoing. The patient previously received ciprofloxacin (CIPRO) for an unknown indication on an unknown date and  experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 20Feb2021, the patient experienced severe muscular pain in both lower extremities extended up to hip area, started 3 days after the shot and continued for 11 days, getting less intense towards the end of the 11 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe muscular pain in both lower extremities extended up to hip area, started 3 days after the shot and continued for11 days, getting less intense towards the end of the 11 days was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Mother states increased cough/elevated temperature/respiratory issues after flu vaccine. Taken to ED on 9/3/17 and placed on ventilator (patient already had tracheostomy-cerebral palsy patient).
Information has been received from a female registered nurse who in 1997 was vaccinated with varicella virus vaccine live. Subsequently, the pt failed to seroconvert, and reported she had a very low titer. Unspecified medical attention was sought. Additional information has been requested.
I woke up this morning and my armpit was really sore. I was starting my day and I felt under my left armpit 2 big lumps. Maybe gland was swallon. I put a heating pad. I read on my side effects and i was fine yesterday and i do have this today. I might as well just report. I also have like a cold.
At about 2:20 am the morning post injection I awoke with a SEVERE headache and nausea. I began vomiting shortly thereafter and continued to vomit for several hours. It wasn't until late the evening after the vaccine that I was able to hold down solid food. The headache continued until the next day and I experienced extreme fatigue (Although that's likely due to the lack of sleep and vomiting for several hours).
This spontaneous report as received from a medical assistant refers to a patient of unknown age. The patient was vaccinated with lot # (667881/0661Z) M-M-R II (dose and route not reported on 06-AUG-2012 that expired on 04-MAY-2012. The patient was not experiencing any known symptoms. Additional information has been requested.
no adverse event occurred, but vaccine was intended to be Moderna Bivalent booster. Monovalent was administered in error.
Patient received second Pfizer vaccine and 10 minutes later started noticing itching and hive like rash at injection site. She also experience dizziness and palpitations. She was given Benadryl, symptoms improved significantly, she was discharged in stable condition.